Agreeco Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 4 Year, 1 Month
- Last Filing with ROC 31 Mar 2022
- Revenue Growth %
- Profit Growth -349.23%
- Ebitda -359.07%
- Net Worth -66.98%
- Total Assets 510.54%
About Agreeco Biotech
Agreeco Biotech Private Limited (ABPL) is a Private Limited Indian Non-Government Company incorporated in India on 30 December 2020 (Four years and one month 8 days old ). Its registered office is in Patna, Bihar, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Jyoti Kumari, Mohd Sajid, and Kapil Shah serve as directors at the Company.
Company Details
-
Location
Patna, Bihar, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U01110BR2020PTC049866
-
Company No.
049866
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
30 Dec 2020
-
Date of AGM
30 Sep 2022
-
Date of Balance Sheet
31 Mar 2022
-
Listing Status
Unlisted
-
ROC Code
Roc Patna
Industry
Who are the key members and board of directors at Agreeco Biotech?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jyoti Kumari
|
Whole-Time Director | 30-Dec-2020 | Current |
|
Mohd Sajid
|
Director | 05-Feb-2024 | Current |
|
Kapil Shah
|
Director | 25-Aug-2023 | Current |
Financial Performance of Agreeco Biotech.
Agreeco Biotech Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 349.23% decrease in profit. The company's net worth observed a substantial decline by a decrease of 66.98%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Agreeco Biotech?
In 2022, Agreeco Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Farmsise Generic Private LimitedJyoti Kumari and Mohd Sajid are mutual person
-
Sevron Seeds India Private Limited
Mohd Sajid is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Agreeco Biotech?
Agreeco Biotech has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Agreeco Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Agreeco Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
